Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P060001/S051

Protege RX Carotid Stent System

Medtronic Vascular, Inc. · Decision date Aug 13, 2025

FDA DECISIONP060001/S051

What did the FDA decide?

FDA records P060001/S051 as a supplement to PMA P060001, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 13, 2025.

FDA approval order statement

a new manufacturing location for delivery system components
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Aug 13, 2025
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P060001/S051
Regulatory pathway
PMA supplement
Product code
NIM
Decision code
OK30
Decision date
Aug 13, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Stent, carotid.

Product code
NIM
FDA device class
3

For the original device and its historical approval scope, see PMA P060001. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P060001 · Original PMA

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

  2. P060001/S051 received

    Application receipt date recorded by FDA.

  3. P060001/S049 · Related supplement

    Protégé RX Carotid Stent System

  4. P060001/S050 · Related supplement

    Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System

  5. P060001/S051 · FDA decision

    30-Day Notice

  6. P060001/S052 · Related supplement

    Protégé GPS self-expanding Peripheral Stent System

  7. P060001/S053 · Related supplement

    Protégé GPS Self-expanding Peripheral Stent System

  8. P060001/S054 · Related supplement

    Protégé RX Carotid Stent System

  9. P060001/S056 · Related supplement

    Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System

  10. P060001/S055 · Related supplement

    Protege RX Carotid Stent System; Protege GPS Self-Expanding Peripheral Stent System

  11. P060001/S057 · Related supplement

    Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Carotid Stent System

  12. P060001/S058 · Related supplement

    Protege GPS Self-expanding Peripheral Stent System

  13. P060001/S059 · Related supplement

    Protégé GPS Self-Expanding Peripheral Stent System; Protégé RX Self-Expanding Carotid Stent System

  14. P060001/S060 · Related supplement

    PROTEGE GPS AND PROTEGE RX CAROTID STENT SYSTEMS

Timeline entries are records held by MedtechLedger for P060001. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P060001

Product / regulatory recordCompanyPathwayDecision dateSource
Medtronic Vascular, Inc.PMA approvalJan 24, 2007FDA
Medtronic Vascular, Inc.PMA supplementJul 17, 2025FDA
Medtronic Vascular, Inc.PMA supplementJul 25, 2025FDA
Medtronic Vascular, Inc.PMA supplementNov 7, 2025FDA
Medtronic Vascular, Inc.PMA supplementDec 16, 2025FDA
Medtronic Vascular, Inc.PMA supplementJan 23, 2026FDA
Medtronic Vascular, Inc.PMA supplementFeb 11, 2026FDA
Medtronic Vascular, Inc.PMA supplementFeb 20, 2026FDA
Medtronic Vascular, Inc.PMA supplementMar 23, 2026FDA
Medtronic Vascular, Inc.PMA supplementJul 10, 2026FDA
Medtronic Vascular, Inc.PMA supplementOct 16, 2026FDA
Medtronic Vascular, Inc.PMA supplementNov 5, 2026FDA

Explore the linked device profile

Other records with product code NIM

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Medtronic Vascular, Inc.

Headquarters
Not reported
Brand website
medtronic.com
FDA applicant address
3033 Campus Dr., Plymouth, MN, 55441

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records